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Key Element Pre Post
1. Is date time of Infusion Complete ? 84% 98%
Abstracts / Biol Blood Marrow Transplant 19 (2013) S167eS177 S171Future: These good clinical practices are leading to error
reduction and increased data validity. Our objective for the
2016 audit is to demonstrate below 1% total errors and attain
reciprocal data between electronic medical records, internal
databases, and CIBMTR by implementing one innovative
process per quarter.2. Is use of Hydration and Premedications indicated
(time of premeds) ?
68% 100%
3. Is Adverse Events completed ? 74% 100%
4. Is product type and cell dose complete ? 72% 95%
5. Is form signed by and Attending ? 95% 94%
6. Is the Start and Stop times completed ? 78% 98%
7. Are the vital sings completed per policy ? 67% 59%
Overall Results 77% 92%TRANSPLANT NURSING-ADMINISTRATION ORAL
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Implementation of an Electronic Form for Hematopoietic
Stem Cell Transplant (HSCT) Infusions Improves
Documentation Compliance
Karen Collum. Nursing, Memorial Sloan - Kettering Cancer
Center, New York, NY
Background: Historically, Hematopoietic Stem Cell (HSC)
Infusionwas documented on a standard paper form available
from a document library throughout the institution. Once
complete, the form remained in the patient's chart until
discharge at which time the chart was scanned into the EMR.
This limited the availability and portability of the informa-
tion. Completion of this form was the responsibility of the
clinician infusing the HSC product. Additionally, HSC infu-
sions are conducted in a variety of units throughout MSKCC.
These areas have been divided into 5 major groups.
The Bone Marrow Transplant Quality Assessment
Committee (BMT QAC) conducted a compliance audit of
infusion documentation. The timeframe used for the audit
was October 2010 through March 2011, which included
a total of 194 transplants. A random selection of 50 trans-
plants (10 from each major group) during this 6 month
period was reviewed; resulting in a total of 60 forms (10 of
which were double cord transplants requiring 2 forms).
Seven key elements of the form were identiﬁed based on
regulatory and institutional requirements and audited for
completeness. The results of the audit indicated that docu-
mentation compliance was 77%.
Intervention: To improve documentation compliance of HSC
Infusions, we developed an electronic infusion form. The
building and testing of the form lasted approximately one
year. Simultaneously, we modiﬁed our vital sign monitoring
parameters for better standardization between different cell
types. During this time period, infusion Standard Operating
Procedure (SOP) was revised to incorporate use of the elec-
tronic document and standardized vital sign parameters. The
design of the electronic form required all ﬁelds to be
complete prior to ﬁnal electronic signature and acceptance of
the form. Additionally, Infusion vitals entered into the elec-
tronic ﬂowsheet by the RN were imported into the note by
the documenting clinician. Subsequent to distribution of the
SOP and training of Stem Cell Transplant service (Physicians,
Nurse Practitioners, Registered Nurses and Cell Processing
Technicians) the form went live in March 2012. Three weeks
post roll out to all areas, the paper form was removed from
the document library; however the form will be available
during system downtime.
Outcome: A follow up audit was conducted to measure
compliance post implementation of electronic documenta-
tion. The timeframe for the audit was April 2012 through July
2012, a total of 209 transplants. Similar to the pre-imple-
mentation audit, a random selection of 50 transplants from
the 5 major groups during this 4 month period were
reviewed for a total of 60 forms. The same 7 key elements of
the form were audited for completeness. The results of the
post implementation audit indicated that compliance ofdocumentation improved from 77% to 92%, an improvement
of 15%.113
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The System Capacity Initiative (SCI), sponsored by the
National Marrow Donor Program (NMDP), was convened to
evaluate and provide recommendations for addressing
workforce and infrastructure challenges for current and
future utilization of blood andmarrow transplant (BMT). The
Nursing Workforce Group (NWG) was established to address
projected shortages of BMT nurses. After surveying BMT
nurses, the NWG identiﬁed several priority challenges,
including the recruitment of nurses to the BMT ﬁeld. In an
effort to increase the number of BMT nurses, an outreach
presentation entitled ‘Introduction to BMT' was developed
and delivered to nursing students throughout the U.S. The
one-hour presentation describes the BMT process, identiﬁes
various nursing roles in BMT, and describes the beneﬁts of
working in this area. A brief pre and post survey is admin-
istered to assess the students' change in awareness of BMTas
a career option, nursing career preferences, likelihood of
pursuing a BMT career, and previous education/training in
BMT after listening to the presentation. To date, the presen-
tation, and pre and post surveys, was delivered to a total of
181 nursing students. The majority of students had not
previously considered a career in BMT (56.9%). However, the
presentation signiﬁcantly increased nursing students'
interest in pursuing a BMT career (N¼61; P < .0001). Addi-
tionally, students' indicated that ‘feeling valued' (62.5%),
‘intellectual stimulation' (66.3%), ‘emotional gratiﬁcation of
providing patient care' (69.5%) and ‘interest in subject
matter' (69.5%) were very important career aspects (see
Figure 1). The NWG in partnership with Oncology Nursing
Society (ONS) and American Society for Blood and Marrow
Transplantation (ASBMT) is continuing to promote the
presentation to increase awareness of BMT nursing as
a career option. It will be available for professional
Abstracts / Biol Blood Marrow Transplant 19 (2013) S167eS177S172development of licensed nurses and continuing nursing
education credit will be provided.
Figure 1. Most Important Aspects of Nursing Career for Nursing Students
Surveyed (N¼181)TRANSPLANT NURSING-CLINICAL ORAL
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Implementation and Maintenance of Practice Guidelines
to Decrease Central Line Associated Bloodstream
Infections by Minimizing Line Manipulation
Kelsey Johnson, Azure Grossman. Blood and Marrow
Transplant, Froedtert Hospital, Milwaukee, WI
Background: The adult blood and marrow transplant pop-
ulation is at high risk for central line associated bloodstream
infections (CLABSI). CLABSI remains a large cause of
morbidity, increased cost, prolonged hospitalization and
mortality in this population. One source of these infections is
line manipulation; speciﬁcally at the central venous access
device (CVAD) needless hub. Several studies have consis-
tently found yeast and heavy bacterial contamination on the
surface of the CVAD hub. Our aim was to decrease line
manipulation in order to decrease our unit's CLABSI rate.
Implementation: In late 2010 our unit practice council
created newguidelines for accessing andmaintaining central
lines. These guidelines included: patients on continuous IVs
will not be disconnected to shower, walk, etc. and patients
whose lines are accessed greater than two time a day
(excluding labs) will remain connected continuously at
a provider prescribed rate. Our deﬁnition of each access
included one connection and disconnection. Nursing staff
were educated about the new guidelines via email and staff
meetings. Providers were educated during a Blood and
Marrow Transplant Program Quality Improvement
Committee meeting. In February of 2012, these guidelines
were revised to include the continuous connection of all
neutropenic patients receiving any IV ﬂuids or medications.
When not neutropenic, we continued to have patients with
greater than two accesses per day connected continuously.
Evaluation: During the 2010 calendar year our inpatient
BMT unit had 13 CLABSI, resulting in a 3.35 CLABSI rate per
1000 patient days. During the 2011 calendar year our inpa-
tient BMT unit had 5 CLABSI, resulting in a 1.27 CLABSI rate
per 1000 patient days. There was a 62 percent reduction in
CLABSI from 2010 to 2011. For the ﬁrst nine months of the
2012 calendar year our inpatient BMT unit has had 3 CLABSI,
resulting in a 1.07 CLABSI rate per 1000 patient days. There
was a 16 percent reduction in CLABSI from 2011 to the ﬁrst 3
quarters of 2012.Discussion: We were able to successfully implement a best
practice based intervention through creating new guidelines
for accessing and maintaining central lines and saw a signif-
icant decrease in our CLABSI rate.
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Improving Reliability of Immunosuppressant Sampling
Techniques
Michelle Kosik 1, Chrissy Boyd 1, Carolyn Zeh 1, Penny Odem1,
Monica Schlatter 2. 1 BMT, Presbyterian/St. Luke's Medical
Center, Denver, CO; 2 Colorado Blood Cancer Institute, Denver,
CO
Problem: The Colorado Blood Cancer Institute BMT Program
at Presbyterian/St. Luke's Medical Center, a member of the
Sarah Cannon Blood Cancer Network, performed 242
hematopoietic cell transplants in 2011. The program noted 14
conﬁrmed TAC/CSA lumen contaminations in 2010. In March
2011, auditing revealed 5 additional contaminations. This
prompted a process improvement initiative. Goals were to
improve quality outcomes by increasing reliability of TAC/
CSA levels and resulting dose adjustments and improve
patient satisfaction with the process (lumen contamination
necessitates peripheral sampling causing increased discom-
fort and risk for patients).
The BMT Leadership team reviewed potential causes:
Forty new staff hired; census and acuity were higher; Trav-
elers and ﬂoat staff were utilized. A process was needed to
ensure TAC/CSA levels were reliable and bedside caregivers
had appropriate knowledge to manage TAC/CSA infusions
and samplings.
Intervention: Immediate efforts focused on nursing staff
re-education.
1. Upon admission, nursing to designate a lumen for TAC/
CSA infusion.
2. No TAC/CSA sampling will be drawn from designated
lumen.
3. TAC/CSA infusion is primary line infusing into dedi-
cated port.
4. TAC/CSA infusion turned off 10 minutes prior to level
sampling.
The unit-based council led this initiative. They recom-
mended alerts to the special nature of these drugs. While
under review, another contamination occurred. Additional
recommendations made:
1. BMT Float guidelines reviewed -TAC/CSA process
added.
2. TAC/CSA process included in traveler orientation
3. RN Resource assigned to new hires, ﬂoats, and
travelers.
4. TAC/CSA education poster displayed on BMT units.
In February 2012, another contamination was noted. The
BMT Leadership team and unit-based council convened to
review additional opportunities.
1. Mandatory Healthstream education developed.
Healthstream is an electronic education system which
includes documentation of compliance.
2. Clamp unused lumens during sampling process.
3. Interdisciplinary collaboration to create a pop up
screen when medication is scanned-“Infuse in desig-
nated lumen ONLY. For help, see your charge nurse.”
